17/09/2007
Dr Dianne Sheehan, President of the Australian Veterinary Association has said that in a joint venture project with Plasvacc, they are trying to find a medical solution to the equine fluenza virus.
17/09/2007
Vet searching for horse flu treatment: The Australian Veterinary Association (AVA) and Plasvacc, a Queensland Biotech company are trying to find a medical solution to the equine influenza virus. Spokespersons have said if infected horses have built a natural immunity to the disease, their blood may be used to treat the immune systems of horses threatened by the virus.
13/09/2007
Sydney Vet & Plasvacc Seek Horse Flu Solution: Plasvacc, Australia's leading producer of animal plasma products and Dr Tim Roberts, the vet in charge of Sydney's Centennial Parkland Equestrian Centre, have formed an alliance to investigate a medical solution for the current equine influenza virus. They believe infected horses "have started to build immunity to the flu virus & plasma drawn from the horses could boost the immune systems of horses faced with the highly contagious disease"
8/08/2007
Breakthrough health treatment: For the past decade, Plasvacc has been at the forefront internationally in developing high-purity
plasma therapy products for livestock, including horses. Dr Ross Wilson, Plasvacc’s co-founder and chief scientific officer, says it’s the quality control of the company’s product that appeals to breeders of high-quality thoroughbreds. “Plasma-based products can augment conventional treatments by shortening the course of treatment and reducing the need for post-operative rehabilitation,” Dr Wilson said. The company has been featured by the Queensland Government as one of its shining stars in promoting the state’s bio-tech industry. Plasvacc is now one of the largest equine plasma suppliers in the US
August 30 - October 3 2007
Pet projects: After increasing revenue by about 35 per cent in the past two years, Plasvacc, Australia's leading commercial provider of animal blood plasma products, is considering a series of US acquisitions that will boost annual sales to around $15 million and a possible sharemarket listing by the end of the year. The deals will also help diversify Plasvacc's product range as currently about 75 per cent of revenue comes from sales of horse plasma products.
(James Thomson)
1/10/2006
Getting ahead of the class: According to industry specialists, the expanding role of a CFO can be enhanced by an MBA. Peter Macarthur, CFO of Plasvacc says completing an MBA helped him both professionally and personally, broadening his opportunities.
(Zilla Efrat)
18/05/2006
Boonah firm to export animal plasma: Plasvacc will soon begin exporting its animal blood plasma products to Europe and North America.
8/12/05
Plasvacc galloping ahead
Malcolm McCosker (courtesy of Queensland Country Life)
Feb 05
Who gets the money: Queensland's Plasvacc has raised $4 million from 130 retail investors. The money was used to buy Veterinary Dynamics Inc (VDI), the market leader in the United States for supply of equine plasma products to veterinarians.
Craig Roberts
9/02/05
QLD blood products firm takes on US market.
Not attributed
8/02/05
Plasvacc will purchase US plasma supplier Veterinary Dynamics for $4 million.
Not attributed
7/02/05
Plasvacc to acquire Veterinary Dynamics Inc (VDI): Co-founder and Chairman Robert Macarthur said the $4 million will give the company fast streamlined access to the world's largest market for animal plasma.
Not attributed
7/02/05
Plasvacc to buy Veterinary Dynamics Inc (VDI)
Not attributed
7/02/05
Plasvacc buys US vet plasma company
Melissa Trudinger
October 2004
Presidents Award: Brian Ramsay, Plasvacc Director, wins prestigious 'Whybird's Presidents Award' at this year's Bendigo Bank Ipswich Chamber of Commerce Business Awards. This 'ultimate accolade' is rewarded on the basis of contribution to business in the Ipswich region over an extended period of time.
Not attributed
23/9/2004
Plasma firm seeks $4.7 million: Major advances in anti-venom applications for animals and humans will flow on from an investment prospectus launched by the blood plasma company Plasvacc.
Malcolm McCosker (p. 6)
6/9/2004
Plasvacc to build Might and Power in the US: Animal plasma supplier Plasvacc saves life of champion racehorse Might and Power.
Andrew Fraser (p. 33)
3/9/2004
Plasvacc to raise $5m for US purchase.
Melissa Trudinger (p. 4)
2/9/2004
Sealing of a relationship: Plasvacc will raise $4.57 million to buy the United States plasma supplier Veterinary Dynamics.
James Thompson (p. 52)
1/9/2004
Plasvacc to raise $5M for US expansion.
Not attributed (p. 11)
31/8/2004
Plasvacc takeover.
Edited by Mark Fenton Jones (p. 48)
28/8/2004
Diary of a Day Trader: Plasvacc mentioned as having recently signed a groundbreaking agreement with CSL's pharmaceutical division.
Not attributed (online)
25/8/2004
Local firm takes on US trade: Blood Plasma provides raw material for vet products. Kalbar company Plasvacc has announced its next step into the world pharmaceutical market with a takeover bid for an established US company.
Peter Foley (p. 3)
25/8/2004
Plasvacc to raise funds for US transfusion.
Liam Walsh (p. 30)
25/8/2004
Global Business Brief: Health – Commercial supplier of blood plasma products for animals Plasvacc is capital raising to purchase US supplier Veterinary Dynamics.
Not attributed (p. 24)
August 2004
Andrew Macarthur, Bob Macarthur and Ross Wilson of Plasvacc are capital raising to fund the purchase of company Veterinary Dynamics Inc. in California on the way to becoming leading animal plasma producers in the world.
Not attributed
29/7/2004
Horse sense: Using cashflow to finance R&D has landed a biotechcompany a contract with CSL
James Thompson (p. 53)
10/2/2003
Medicine takes the horse course: Plasvacc are poised to take their research into the treatment of human disease
Amanda Gearing (p. 31)
4/6/2004
CSL outsources to Plasvacc
Not attributed (p. 3)
3/6/2004
Plasma snake safety boost: Greater protection from snakebite in humans and animals will emerge from a deal struck with Plasvacc and CSL
Not attributed (p. 8)
1/6/2004
Horse plasma deal: Queensland biotech company Plasvacc signs deal with CSL
Not attributed (p. 47)
1/6/2004
Horse gift aids snake victims
Peter Foley (p. 3)
26/5/2004
Kalbar Biotech signs deal with CSL: Major supply agreement opens way to new human applications
Not attributed (p. 3)
25/5/2004
Plasvacc wins horse plasma deal with CSL
Not attributed (p. 23)
25/5/2004
Spotlight: Plasvacc to supply CSL with plasma
Not attributed (p. 41)
25/5/2004
CSL outsources anti-venom production to Plasvacc
Melissa Trudinger (online)
24/5/2004
Plavacc wins deal to provide horse plasma to CSL
AAP
8/10/2003
In the News: Grant will help Plasvacc go global
Not attributed (p. 6)
28/10/2004
Blood pumps life into idea
Belinda Seeney (p. 3)
23/8/2003
Blood money follows a period of careful planning
Pam Kershaw (p. 56)
23/7/2003
Have you heard....? Plasvacc lifts profile - again
Not attributed (p.3)
23/6/2003
Plasvacc banks on US clearance for plasma
Guy Mosel (p. 15)
^top
